NCT01904747
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.
NCT01904747
NCT01138371
NCT00283387
NCT01752296
NCT00074971
NCT01475474
NCT00000595
Not specified
NCT01995149
Not specified
NCT01407874
NCT01265264